Policy changes Backwork has recorded, newest first. The most recent change on record is from October 24, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
86,510 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| Aug 1, 2026 | Blue Shield of California | Cervical Spine Surgery | Retired |
| Aug 1, 2026 | Blue Shield of California | Ambulatory Surgery Center | Retired |
| Aug 1, 2026 | Blue Shield of California | Skeletal Remodeling | New policy |
| Aug 1, 2026 | Blue Shield of California | Prostate Artery Embolization for Benign Prostatic Hyperplasia | New policy |
| Aug 1, 2026 | Blue Shield of California | Place of Service Policy for Outpatient Procedures | New policy |
| Aug 1, 2026 | Blue Shield of California | Noninvasive Fetal RHD Genotyping Using Cell-Free Fetal DNA | New policy |
| Aug 1, 2026 | Blue Shield of California | Investigational Services | Metadata changed |
| Aug 1, 2026 | Blue Shield of California | Evaluation of Cerebrospinal fluid, Urine, and Plasma Tests for Alzheimer Disease | New policy |
| Aug 1, 2026 | Blue Shield of California | Circulating Tumor-Tissue-Modified Viral DNA Testing for Cancer Management | New policy |
| Aug 1, 2026 | Blue Shield of California | Cartilage Implants for Joint Pain | New policy |
| Aug 1, 2026 | Blue Shield of California | Applied Behavior Analysis for Autism Spectrum Disorder or Pervasive Developmental Disorder | Metadata changed |
| Aug 1, 2026 | BlueCross BlueShield of Tennessee | Zoledronic Acid (Zometa) | Metadata changed |
| Aug 1, 2026 | BlueCross BlueShield of Tennessee | Zoledronic Acid (Reclast) | Metadata changed |
| Aug 1, 2026 | BlueCross BlueShield of Tennessee | Urinary Metabolite Tests for Adherence to Direct-Acting Antiviral Medications for Hepatitis C | Metadata changed |
| Aug 1, 2026 | BlueCross BlueShield of Tennessee | Trabectedin (Yondelis, Evdi) | Metadata changed |
| Aug 1, 2026 | BlueCross BlueShield of Tennessee | Thermography | Metadata changed |
| Aug 1, 2026 | BlueCross BlueShield of Tennessee | Testosterone Product: (Testosterone Pellets [Testopel]) | Metadata changed |
| Aug 1, 2026 | BlueCross BlueShield of Tennessee | Teclistamab-cqyv (Tecvayli) | Metadata changed |
| Aug 1, 2026 | BlueCross BlueShield of Tennessee | Talquetamab-tgvs(Talvey) | Metadata changed |
| Aug 1, 2026 | BlueCross BlueShield of Tennessee | Stem Cell Therapy for Peripheral Artery Disease | Metadata changed |
| Aug 1, 2026 | BlueCross BlueShield of Tennessee | Ustekinumab Products: Ustekinumab (Stelara); Ustekinumab-auub (Wezlana); Ustekinumab-srlf (Imuldosa); Ustekinumab-aauz (Otulfi); Ustenkinumab-ttwe (Pyzchiva), Ustekinumab-aekn (Selarsdi); Ustenkinumab-stba (Steqeyma); Ustenkinumba-kfce (Yesintek); ustekinumab; ustekinumab-aauz, ustekinumab-stba, ustekinumab-aekn ; ustenkinumab-ttwe; Ustekinumab-hmny (Starjemza) | Metadata changed |
| Aug 1, 2026 | BlueCross BlueShield of Tennessee | Spesolimab-sbzo (Spevigo) | Metadata changed |
| Aug 1, 2026 | BlueCross BlueShield of Tennessee | Zoster Vaccine Recombinant, Adjuvanted | Metadata changed |
| Aug 1, 2026 | BlueCross BlueShield of Tennessee | Serum Biomarker Panel Testing for Systemic Lupus Erythematosus and Other Connective Tissue Diseases | Metadata changed |
| Aug 1, 2026 | BlueCross BlueShield of Tennessee | Romidepsin [Istodax; Romidepsin (liquid)] | Metadata changed |
| Aug 1, 2026 | BlueCross BlueShield of Tennessee | Valoctocogene Roxaparvovec‐rvox (Roctavian) | Metadata changed |
| Aug 1, 2026 | BlueCross BlueShield of Tennessee | Rituximab Products (Rituxan, Rituximab-abbs [Truxima],Rituximab-arrx [Riabni] and Rituximab-pvvr [Ruxience]) (Oncology Indications) | Metadata changed |
| Aug 1, 2026 | BlueCross BlueShield of Tennessee | Rituximab Products (Rituxan, Rituximab-abbs [Truxima],Rituximab-arrx [Riabni] and Rituximab-pvvr [Ruxience]) (Non-Oncology Indications) | Metadata changed |
| Aug 1, 2026 | BlueCross BlueShield of Tennessee | Risankizumab-rzaa (Skyrizi) | Metadata changed |
| Aug 1, 2026 | BlueCross BlueShield of Tennessee | Retifanlimab-dlwr (Zynyz) | Metadata changed |
| Aug 1, 2026 | BlueCross BlueShield of Tennessee | Remestemcel-L-rknd (Ryoncil) | Metadata changed |
| Aug 1, 2026 | BlueCross BlueShield of Tennessee | Radiofrequency Tissue Volume Reduction (RFTVR) for the Treatment of Upper Airway Obstruction | Metadata changed |
| Aug 1, 2026 | BlueCross BlueShield of Tennessee | Radioembolization for Primary Tumors and Metastatic Tumors to the Liver | Metadata changed |
| Aug 1, 2026 | BlueCross BlueShield of Tennessee | Proton Beam Therapy | Metadata changed |
| Aug 1, 2026 | BlueCross BlueShield of Tennessee | Prademagene Zamikeracel (Zevaskyn) | Metadata changed |
| Aug 1, 2026 | BlueCross BlueShield of Tennessee | Plasminogen, human-tvmh (Ryplazim) | Metadata changed |
| Aug 1, 2026 | BlueCross BlueShield of Tennessee | Plasma Exchange | Metadata changed |
| Aug 1, 2026 | BlueCross BlueShield of Tennessee | Photodynamic Therapy (PDT) for the Treatment of Certain Cancers | Codes changed |
| Aug 1, 2026 | BlueCross BlueShield of Tennessee | Photodynamic Therapy (PDT) for the Treatment of Certain Cancers | Metadata changed |
| Aug 1, 2026 | BlueCross BlueShield of Tennessee | Pharmacogenetic Testing for Pain Management | Metadata changed |
| Aug 1, 2026 | BlueCross BlueShield of Tennessee | Pemetrexed (Alimta; Pemfexy, Pemetrexed, Pemrydi RTU, Axtle) | Metadata changed |
| Aug 1, 2026 | BlueCross BlueShield of Tennessee | Pegcetacoplan (Syfovre) | Metadata changed |
| Aug 1, 2026 | BlueCross BlueShield of Tennessee | Pasireotide (Signifor LAR) | Metadata changed |
| Aug 1, 2026 | BlueCross BlueShield of Tennessee | Lumasiran (Oxlumo) | Metadata changed |
| Aug 1, 2026 | BlueCross BlueShield of Tennessee | Orthoptic Training for the Treatment of Vision or Learning Disabilities | Metadata changed |
| Aug 1, 2026 | BlueCross BlueShield of Tennessee | Ophthalmologic Techniques for the Evaluation of Glaucoma | Metadata changed |
| Aug 1, 2026 | BlueCross BlueShield of Tennessee | Patisiran Lipid Complex (Onpattro) | Metadata changed |
| Aug 1, 2026 | BlueCross BlueShield of Tennessee | Onasemnogene Abeparvovec-xioi (Zolgensma) | Metadata changed |
| Aug 1, 2026 | BlueCross BlueShield of Tennessee | Olipudase Alfa-rpcp (Xenpozyme) | Metadata changed |
| Aug 1, 2026 | BlueCross BlueShield of Tennessee | Octreotide Suspension (Sandostatin LAR Depot), Octreotide Acetate for Injectable Suspension | Metadata changed |